User:SDZeroBot/NPP sorting/STEM/Chemistry: Difference between revisions

Revision as of 02:00, 19 August 2025

Revision as of 01:46, 31 August 2025

(23 intermediate revisions by the same user not shown)

Line 1:

{{User:SDZeroBot/NPP sorting/header|count=1620|date=1931 August 2025|ts=0201:0046, 1931 August 2025 (UTC)}}

{| class="wikitable sortable"

Line 9:

! scope="col" style="width: 10em;" | Creator (# edits)

! scope="col" style="width: 4em;" | Notes

|-

| 2024-1201-1715

| [[ErbiumGadolinium(III) sulfateselenate]] <small>(Chemical compound)</small>

| Gadolinium(III) selenate is an inorganic compound with the [[chemical formula]] Gd₂(SeO₄)₃. It exists as the anhydrate and octahydrate. The octahydrate transforms into the anhydrate when heated to 130&nbsp;°C.

| Stub

| data-sort-value=257122447 | [[Special:Contribs/MahmoudalrawiPraseodymium-141|MahmoudalrawiPraseodymium-141]] (257122447)

|

|-

| 2024-01-11

| [[SoziniberceptSamarium(III) antimonide]] <small>(PharmaceuticalChemical compound)</small>

| Samarium antimonide is a binary inorganic compound of [[samarium]] and [[antimony]] with the formula SmSb. It forms crystals.

| Stub

| data-sort-value=26022447 | [[Special:Contribs/Mo18ekulaPraseodymium-141|Mo18ekulaPraseodymium-141]] (26022447)

|

|-

| 2024-01-18

| [[Porous polymer]]

| Porous polymers are a class of [[porous media]] materials in which [[monomer]]s form [[2D polymer|2D]] and [[3D polymers]] containing angstrom- to nanometer-scale pores formed by the arrangement of the monomers. They may be either crystalline or amorphous. Subclasses include [[covalent organic framework]]s (COFs), [[hydrogen-bonded organic framework]]s (HOFs), [[metal-organic framework]]s (MOFs), and [[porous organic polymer]]s (POPs).

| Start

| data-sort-value=3748895 | [[Special:Contribs/HoffmacsMichael7604|HoffmacsMichael7604]] (3748895)

|

|-

| 2024-01-22

| [[Praseodymium monoselenide]] <small>(Chemical compound)</small>

| Erbium(III)Praseodymium carbonatemonoselenide is an [[erbium]]a compound with the [[chemical formula]] {{chem2|Er2(CO3)3}}PrSe. It forms crystals.

| Stub

| data-sort-value=49422447 | [[Special:Contribs/SlavxePraseodymium-141|SlavxePraseodymium-141]] (49422447)

|

|-

| 2024-01-26

| [[Iron(III) selenite]] <small>(Chemical compound)</small>

| Iron(III) selenite is an inorganic compound with the chemical formula Fe₂(SeO₃)₃. It exists anhydrous form and as various hydrates. The heptahydrate is produced by the reaction of [[ferric chloride]] and [[selenous acid]] (or [[sodium selenite]]) at a pH of 1.05.

| Start

| data-sort-value=22447 | [[Special:Contribs/Praseodymium-141|Praseodymium-141]] (22447)

|

|-

| 2024-11-10

Line 14 ⟶ 49:

| Qing-Yun Chen ({{zh|s=陈庆云|p=Chén Qìngyún}}; 25 January 1929 – 2 March 2023) was a Chinese [[organic chemist]] and member of the [[Chinese Academy of Sciences]], specializing in the field of organic fluorine chemistry.

| Start

| data-sort-value=83318392 | [[Special:Contribs/Tokisaki Kurumi|Tokisaki Kurumi]] (83318392)

|

|-

| 20252024-0501-3110

| [[Fudosteine]] <small>(Chemical compound)</small>

| [[Musahaqah]]

| Fudosteine (Cleanal) is a [[mucolytic agent]]. In Japan, it is approved for the treatment of [[bronchial asthma]], [[chronic bronchitis]], [[pulmonary emphysema]], [[bronchiectasis]], [[pulmonary tuberculosis]], [[pneumoconiosis]], atypical [[mycobacterial disease]], and [[diffuse panbronchiolitis]].

| Musaheqeh ({{Langx|ar|مساحقه}}) is a legal and religious term. In [[Fiqh|Islamic jurisprudence]] ([[fiqh]]) and under the [[Islamic Penal Code of Iran]], musaheqeh refers to a situation in which an adult, mentally competent, and consenting [[woman]] brings her [[Sex organ|genitalia]] into contact with the genitalia of another woman.

| Stub

| data-sort-value=26685014 | [[Special:Contribs/JesusisGreat7Innerstream|JesusisGreat7Innerstream]] (26685014)

|

|-

Line 35 ⟶ 70:

| ¹⁷⁷Lu-NNS309 is an investigational radiopharmaceutical compound currently under development by Novartis Pharmaceuticals for the treatment of various [[Neoplasm|solid tumors]]. The compound is being evaluated in Phase I clinical trials for patients with pancreatic, lung, breast, and colorectal cancers.

| C

| data-sort-value=55665704 | [[Special:Contribs/Noxoug1|Noxoug1]] (55665704)

|

|-

| 2025-08-08

| [[Sozinibercept]] <small>(Pharmaceutical compound)</small>

| Sozinibercept was an [[investigational drug]] intended to be used to treat certain eye conditions such as wet [[age-related macular degeneration]] (AMD). It is administered [[Intravitreal injection|intravitreally]] in combination with other Anti-[[VEGF-A]] including [[aflibercept]], [[faricimab]], [[ranibizumab]], and [[bevacizumab]].

| Start

| data-sort-value=2571 | [[Special:Contribs/Mahmoudalrawi|Mahmoudalrawi]] (2571)

|

|-

Line 49 ⟶ 77:

| OpRegen (also known as RG6501) is an investigational allogeneic cell therapy developed by Lineage Cell Therapeutics for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The therapy consists of human retinal pigment epithelial (RPE) cells administered via subretinal injection as a single treatment.

| C

| data-sort-value=55665704 | [[Special:Contribs/Noxoug1|Noxoug1]] (55665704)

|

|-

Line 56 ⟶ 84:

| Vatinoxan, originally known as MK-467, is an [[Alpha-2_adrenergic_receptor#Antagonists|α₂-adrenergic receptor antagonist]] used in veterinary medicine alongside [[Alpha-2_adrenergic_receptor#Agonists|α₂-adrenergic receptor agonists]] to counteract [[vasoconstriction]] and [[hypertension]] while maintaining sedation. Vatinoxan does not cross the [[blood–brain barrier]] giving it a unique pharmacological profile compared to the other α₂-adrenergic receptor antagonists and distinct clinical application.

| C

| data-sort-value=493499 | [[Special:Contribs/Sacristy|Sacristy]] (493499)

|

|-

| 2024-12-17

| [[Dazadrol]] <small>(Dazadrol is an antidepressant)</small>

| Dazadrol is a synthetic [[antidepressant]] developed by [[Schering-Plough|Schering Corp]] in the late 1960s. It acts primarily as a [[noradrenaline reuptake inhibitor]], increasing concentrations of noradrenaline in the [[synaptic cleft]], which is believed to underlie its antidepressant effects.

| Stub

| data-sort-value=260 | [[Special:Contribs/Mo18ekula|Mo18ekula]] (260)

|

|-

| 2025-08-13

| [[Structural Dynamics Response Assay]] <small>(Biochemical analysis procedure)</small>

| The structural dynamics response (SDR) assay is a type of [[biophysical]] test used to measure [[ligand binding]] to a target [[protein]]. The assay is configured as a simple mix and read format that can be conducted in very low volumes, therefore suitable for [[drug discovery]] applications such as [[high throughput screening]] (HTS), or in the development of a drug candidate during [[medicinal chemistry]] optimization cycles.

| Start

| data-sort-value=374 | [[Special:Contribs/Hoffmacs|Hoffmacs]] (374)

|

|-

| 2025-08-12

| [[Erbium(III) sulfate]] <small>(Chemical compound)</small>

| Erbium(III) sulfate is an [[erbium]] compound with the [[chemical formula]] {{chem2|Er2(SO4)3}}. It is a pink crystalline salt, readily absorbing water to form an octahydrate. It is used as a [[Colourant|colorant]] in [[glass manufacturing]] and [[porcelain enamel]] glazes, as well as a [[dopant]] in the production of [[optical fiber]].

| Stub

| data-sort-value=494 | [[Special:Contribs/Slavxe|Slavxe]] (494)

|

|-

Line 91 ⟶ 98:

| Sefaxersen (also known as RO7434656, RG6299, ISIS-696844 and IONIS-FB-LRx) is an investigational [[antisense oligonucleotide]] (ASO) drug developed by [[Roche Holding AG]] in partnership with [[Ionis Pharmaceuticals]]. It targets [[complement factor B]] (CFB) to treat [[complement system]]-mediated diseases, primarily [[IgA nephropathy]] (IgAN) and [[geographic atrophy]] (GA) secondary to [[age-related macular degeneration]].

| C

| data-sort-value=55665704 | [[Special:Contribs/Noxoug1|Noxoug1]] (55665704)

|

|-

| 2025-08-1118

| [[Plutonium(III)Jens phosphateBruun de Neergaard]] <small>(ChemicalDanish judge and compoundlandowner)</small>

| Jens Bruun de Neergaard (14 June 1742 – 22 April 1788) was a [[Denmark|Danish]] judge and landowner. He owned [[Svenstrup (manor house)|Svenstrup Manor]], at [[Borup, Køge|Broup]], [[Køge Municipality]], whouse present main building he constructed in the 1780s. On 31 May 1780, alongside his younger brother, Johan Thomas de Neergaard (1745–1806), he was ennobled by [[letters patent]].

| Plutonium(III) phosphate is an [[inorganic compound]] of [[plutonium]], with the molecular formula {{chem2|PuPO4}}. It is the trivalent plutonium salt of [[phosphoric acid]].

| Start

| data-sort-value=410788166 | [[Special:Contribs/Laura240406Ramblersen2|Laura240406Ramblersen2]] (410788166)

|

|-

| 2025-08-1504

| [[ErbiumHellenic Championship (IIITennis) carbonate]] <small>(ChemicalTennis compoundtournament)</small>

| The Hellenic Championship is an [[ATP 250 tournaments|ATP 250 tournament]] held in [[Athens]], [[Greece]]. The event is played on indoor [[hardcourt]] at the [[OAKA Basketball Arena]], a multi-purpose venue that was used for the [[2004 Summer Olympics]]. It replaces the [[Belgrade Open]] on the calendar and it is scheduled to debut in November 2025.

| Erbium(III) carbonate is an [[erbium]] compound with the [[chemical formula]] {{chem2|Er2(CO3)3}}.

| StartStub

| data-sort-value=41074021 | [[Special:Contribs/Laura240406Haddad Maia fan|Laura240406Haddad Maia fan]] (41074021)

|

|-

| 2025-08-1813

| [[Structural Dynamics Response Assay]] <small>(Biochemical analysis procedure)</small>

| [[Saudi Green and Middle East Green Initiatives]]

| The structural dynamics response (SDR) assay is a type of [[biophysical]] test used to measure [[ligand binding]] to a target [[protein]]. The assay is configured as a simple mix and read format that can be conducted in very low volumes, therefore suitable for [[drug discovery]] applications such as [[high throughput screening]] (HTS), or in the development of a drug candidate during [[medicinal chemistry]] optimization cycles.

| Saudi Green and Middle East Green Initiatives have been established on March 27, 2021, by Saudi Crown Prince [[Mohammed bin Salman]]. These programs are designed to expand vegetation cover, cut carbon emissions, fight pollution and land degradation, and safeguard wildlife.

| Start

| data-sort-value=340374 | [[Special:Contribs/RavanHoffmacs|RavanHoffmacs]] (340374)

|

|-

| 2025-08-1827

| [[1-Isocyano-5-aminonaphthaleneFerrugine]] <small>(chemicalChemical compound)</small>

| Ferrugine is a [[tropane alkaloid]] discovered in the basic [[extract]] of the Australian rainforest tree ''[[Darlingia ferruginea]]'' where it occurs in the leaves and stems. The structure has been [[Chemical_structure#Structural_elucidation|determined]] through [[spectroscopic analysis]] and confirmed by [[chemical synthesis]].

| 1-Isocyano-5-aminonaphthalene (commonly ICAN) is a substituted naphthalene bearing an [[isocyano]] (–N≡C) group and an [[amino]] (–NH{{sub|2}}) group in a 1,5-relationship. The push–pull pairing of an [[electron donor]] (amino) and an [[electron-withdrawing]] (isocyano) group gives ICAN a pronounced [[intramolecular charge-transfer]] (ICT) character, which underlies its strong [[solvatochromic fluorescence]] and its use as an environment-sensitive fluorophore.

| Stub

| data-sort-value=0 | [[Special:Contribs/2.101.56.53|2.101.56.53]]

|

|-

| 2025-08-0822

| [[Zimei Bu]] <small>(researcher)</small>

| Zimei Bu, PhD is a protein chemist in the [[City College of New York]], where she is Professor of Chemistry and Biochemistry and Laboratory Director.

| Stub

| data-sort-value=24 | [[Special:Contribs/Wang Walton|Wang Walton]] (24)

|

|-

| 2025-0805-1304

| [[Erythrocyte-based drug delivery]] <small>(Drug delivery method)</small>

| Erythrocyte-based drug delivery systems (EBDDS) use [[red blood cells]], their membranes, or their components to release and deliver pharmaceutical agents throughout the body in a controlled manner. Because red blood cells circulate for long periods of time and are potentially non-[[immunogenic]], they are an attractive vector for [[drug delivery]] via the circulatory system.

| C

| data-sort-value=56 | [[Special:Contribs/MikicsekDrugDelivery2025|MikicsekDrugDelivery2025]] (56)

|

|-

| 2004-07-29

| [[Figure of Insensitivity]]

| Figure of Insensitivity (''F of I'') is an inverse scale of measure of the impact [[shock sensitivity|sensitivity]] of an [[explosive]] substance. In this particular context the term 'Insensitivity' refers to the likelihood of initiation/[[detonation]] by impact, [[friction]], [[electrostatic discharge]], application of [[flame]], etc.

| Start

| data-sort-value=0 | [[Special:Contribs/20.133.0.11|20.133.0.11]]

|

|}

<span style="font-style: italic; font-size: 85%;">Last updated by [[User:SDZeroBot|SDZeroBot]] ^{''[[User:SD0001|operator]] / [[User talk:SD0001|talk]]''} at 0201:0046, 1931 August 2025 (UTC)</span>